Early postoperative intraocular pressure pattern in glaucomatous and nonglaucomatous patients

J Cataract Refract Surg. 1996 Jun;22(5):607-11. doi: 10.1016/s0886-3350(96)80018-6.

Abstract

Purpose: To evaluate intraocular pressure (IOP) changes in the 24 hours following cataract extraction in glaucomatous and nonglaucomatous patients.

Setting: General Eye Service and Glaucoma Service of the Goldschleger Eye Institute, Tel Hashomer, Israel.

Methods: Twenty-six nonglaucomatous patients and 13 glaucomatous patients scheduled for routine cataract extraction and intraocular lens implantation were evaluated. In each patient, IOP was measured before cataract surgery and every 4 hours for 24 hours postoperatively. Thirteen of the nonglaucomatous patients were randomly treated with one drop of timolol maleate at the end of surgery (NG-T group). The other 13 nonglaucomatous patients (NG group) and all glaucoma patients (G group) were not treated.

Results: In the NG group, mean preoperative IOP was 13.9 mm Hg. Following surgery, IOP rose steadily to 22.2 mm Hg at 12 hours; it returned to almost presurgical levels at 24 hours. The IOP exceeded 35 mm Hg in only one patient. In the NG-T group, mean preoperative IOP was 16.5 mm Hg and increased to 21.2 mm Hg at 12 hours. The IOP returned to almost presurgical levels at 24 hours. In the G group, mean IOP was 18.8 mm Hg preoperatively and rose to 29.9 mm Hg at 8 hours after surgery. In seven eyes the IOP exceeded 35 mm Hg.

Comments: Our findings of elevated IOP emphasize the need for prophylactic treatment (medical or combined cataract and glaucoma surgery) to prevent IOP spikes in high-risk patients.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Acetazolamide / therapeutic use
  • Administration, Topical
  • Adrenergic beta-Antagonists / therapeutic use
  • Aged
  • Carbonic Anhydrase Inhibitors / therapeutic use
  • Cataract Extraction*
  • Circadian Rhythm
  • Drug Therapy, Combination
  • Female
  • Follow-Up Studies
  • Glaucoma, Open-Angle / drug therapy
  • Glaucoma, Open-Angle / physiopathology*
  • Humans
  • Intraocular Pressure* / physiology
  • Lenses, Intraocular
  • Male
  • Ocular Hypertension / drug therapy
  • Ocular Hypertension / physiopathology*
  • Postoperative Period
  • Random Allocation
  • Risk Factors
  • Timolol / therapeutic use

Substances

  • Adrenergic beta-Antagonists
  • Carbonic Anhydrase Inhibitors
  • Timolol
  • Acetazolamide